UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058350
Receipt number R000066704
Scientific Title Comparison of Outcome Between Nursing Care Using NANDA-I, NOC, and NIC Frameworks and Routine Nursing Care for Elderly Aged 65 and Over with Frailty Syndrome
Date of disclosure of the study information 2025/07/03
Last modified on 2025/07/02 20:01:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on frailty care using NNN-based nursing plans in home visiting nursing

Acronym

NNN-Frailty Study

Scientific Title

Comparison of Outcome Between Nursing Care Using NANDA-I, NOC, and NIC Frameworks and Routine Nursing Care for Elderly Aged 65 and Over with Frailty Syndrome

Scientific Title:Acronym

NNN-Frailty Quasi-Exp

Region

Japan


Condition

Condition

Frailty syndrome in older adults

Classification by specialty

Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to examine the effectiveness of nursing care using NANDA-I, NOC, and NIC (NNN) for care-dependent older adults diagnosed with frailty syndrome, by comparing it with usual nursing care.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in outcome indicators based on the Nursing Outcomes Classification (NOC)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Visiting nurses provide nursing care based on standardized nursing languages including NANDA-I, NIC, and NOC, and evaluate nursing outcomes after 12 weeks.

Interventions/Control_2

Home-visiting nurses provide usual care based on conventional nursing processes without standardized language. Evaluation is performed at 12 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

120 years-old >=

Gender

Male and Female

Key inclusion criteria

Individuals diagnosed with frailty syndrome in older adults.

Individuals confirmed to have a level of independence of IIb or lower in daily life for elderly people with dementia, based on information provided by their care manager.

Individuals who have given informed consent to participate in the study.

Key exclusion criteria

Individuals diagnosed by a physician as having a prognosis of less than six months.

Individuals facing an urgent and apparent life-threatening condition.

Individuals requiring prioritized medical interventions due to high risk of physical injury or other serious conditions.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Keiko
Middle name
Last name Kira

Organization

Shonan Kamakura University of Medical Sciences, Graduate School

Division name

Graduate School of Nursing

Zip code

247-0066

Address

1195-3 Yamazaki, Kamakura-shi, Kanagawa, Japan

TEL

0467-38-3131

Email

soumu@sku.ac.jp


Public contact

Name of contact person

1st name keiko
Middle name
Last name kira

Organization

Shonan Kamakura University of Medical Sciences, Graduate School

Division name

Graduate School of Nursing

Zip code

247-0066

Address

1195-3 Yamazaki, Kamakura-shi, Kanagawa, Japan

TEL

0467-38-3131

Homepage URL


Email

soumu@sku.ac.jp


Sponsor or person

Institute

Shonan Kamakura University of Medical Sciences, Graduate School

Institute

Department

Personal name



Funding Source

Organization

Shonan Kamakura University of Medical Sciences, Graduate School

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shonan Kamakura University of Medical Sciences, Graduate School

Address

1195-3 Yamazaki, Kamakura-shi, Kanagawa 247-0066, Japan

Tel

0467-38-3131

Email

soumu@sku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 06 Month 30 Day

Date of IRB


Anticipated trial start date

2025 Year 07 Month 03 Day

Last follow-up date

2026 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 07 Month 02 Day

Last modified on

2025 Year 07 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066704